Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2018 Earnings

20FebConfirmed

Q2 2017

Q3 2017

Q4 2017

Q1 2018

-0.26

0.11

0.48

0.85

Details

Expected EPS

0.8

Actual EPS

0.85

Surprise EPS

0.05

Surprise Percent

+6.25%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.85 per share for Q1 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.